跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUDENOFALK budesonide 3 mg enteric capsules - TGA Drug Approval Details
Approvals
/
TGA
/
BUDENOFALK budesonide 3 mg enteric capsules
Approved
STANDARD
BUDENOFALK budesonide 3 mg enteric capsules
Dr Falk Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
77da458ed0f4316c
Company
Dr Falk Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
77da458ed0f4316c
Product Name
BUDENOFALK budesonide 3 mg enteric capsules
Artg Id
179566
Artg Name
BUDENOFALK budesonide 3 mg enteric capsule blister pack
Sponsor
Dr Falk Pharma Australia Pty Ltd
Company Detail Path
/organization/dr-falk-pharma-australia-pty-ltd
Artg Date
2012-06-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2a4cd8b2aa906aa91187850b7952c0a5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c491d5781c5c6c7d239f9e8ecede82b6.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
77da458ed0f4316c
Type
Standard
Back to TGA Approvals